-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Amrize, Raises Price Target to $70

Benzinga·03/05/2026 21:02:03
Listen to the news
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $60 to $70.